FDA approval of new Alzheimer's drug Aduhelm, developed in part by Brown researchers, mired in controversy

The Brown Daily Herald

Jul 20, 2021

The Food and Drug Administration approved a new drug Aduhelm for the treatment of Alzheimer's disease June 7 through its accelerated approval pathway. While some patient advocacy g…